摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(4-bromophenyl)-1-{3-[4-(3-acetylaminophenyl)piperidin-1-yl]propyl}-1H-benzimidazole | 1081111-15-0

中文名称
——
中文别名
——
英文名称
2-(4-bromophenyl)-1-{3-[4-(3-acetylaminophenyl)piperidin-1-yl]propyl}-1H-benzimidazole
英文别名
N-[3-[1-[3-[2-(4-bromophenyl)benzimidazol-1-yl]propyl]piperidin-4-yl]phenyl]acetamide
2-(4-bromophenyl)-1-{3-[4-(3-acetylaminophenyl)piperidin-1-yl]propyl}-1H-benzimidazole化学式
CAS
1081111-15-0
化学式
C29H31BrN4O
mdl
——
分子量
531.495
InChiKey
VGOMSEQXNMIQQZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    35
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.31
  • 拓扑面积:
    50.2
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    3-[4-(3-acetylaminophenyl)piperidin-1-yl]propan-1-ol 在 potassium carbonate三乙胺 作用下, 以 二氯甲烷N,N-二甲基甲酰胺 为溶剂, 反应 8.0h, 生成 2-(4-bromophenyl)-1-{3-[4-(3-acetylaminophenyl)piperidin-1-yl]propyl}-1H-benzimidazole
    参考文献:
    名称:
    Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists
    摘要:
    Compounds containing 2-arybenzimidazole ring systems linked to arylpiperidines were synthesized and evaluated as MCH-R1 antagonists. The results of structure-activity relationship studies led to the identification of compound 4c as a potent MCH-R1 antagonist (IC50 = 1 nM). This compound also has good metabolic stability, and favorable pharmacokinetic and brain penetration properties. However 4c was found to be potent inhibitor of the hERG potassium channel. (C) 2011 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2011.02.099
点击查看最新优质反应信息

文献信息

  • IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
    申请人:Suh Jee Hee
    公开号:US20100145054A1
    公开(公告)日:2010-06-10
    The present invention is directed to a novel imidazole derivative having an aryl piperidine substituent of formula (I) and a method for preparation thereof, and a pharmaceutical composition containing said imidazole derivative as an active ingredient for preventing or treating a MCH (melanine-concentrating hormone)-related disease.
    本发明涉及一种具有式(I)的芳基哌啶取代基的新型咪唑衍生物及其制备方法,以及含有该咪唑衍生物作为活性成分的药物组合物,用于预防或治疗与MCH(黑色素浓集激素)相关的疾病。
  • US8198307B2
    申请人:——
    公开号:US8198307B2
    公开(公告)日:2012-06-12
  • [EN] IMIDAZOLE DERIVATIVES HAVING ARYL PIPERIDINE SUBSTITUENT, METHOD FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME<br/>[FR] DÉRIVÉS D'IMIDAZOLE AVEC UN SUBSTITUANT ARYL-PIPÉRIDINE, LEUR PROCÉDÉ DE PRÉPARATION ET DES COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
    申请人:KOREA RES INST CHEM TECH
    公开号:WO2008140239A1
    公开(公告)日:2008-11-20
    [EN] The present invention is directed to a novel imidazole derivative having an aryl piperidine substituent of formula (I) and a method for preparation thereof, and a pharmaceutical composition containing said imidazole derivative as an active ingredient for preventing or treating a MCH (melanine-concentrating hormone)-related disease.
    [FR] La présente invention concerne un nouveau dérivé d'imidazole avec un substituant aryl-pipéridine de formule (I) et son procédé de préparation ainsi qu'une composition pharmaceutique renfermant ledit dérivé d'imidazole en tant que principe actif destiné à la prévention ou au traitement d'une maladie liée à la MCH (hormone de concentration de la mélanine).
  • Synthesis and SAR investigations of novel 2-arylbenzimidazole derivatives as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists
    作者:Chae Jo Lim、Nakjeong Kim、Eun Kyoung Lee、Byung Ho Lee、Kwang-Seok Oh、Sung-eun Yoo、Kyu Yang Yi
    DOI:10.1016/j.bmcl.2011.02.099
    日期:2011.4
    Compounds containing 2-arybenzimidazole ring systems linked to arylpiperidines were synthesized and evaluated as MCH-R1 antagonists. The results of structure-activity relationship studies led to the identification of compound 4c as a potent MCH-R1 antagonist (IC50 = 1 nM). This compound also has good metabolic stability, and favorable pharmacokinetic and brain penetration properties. However 4c was found to be potent inhibitor of the hERG potassium channel. (C) 2011 Elsevier Ltd. All rights reserved.
查看更多